Actively Recruiting
Noninvasive Molecular Test to Detect Colorectal Polyps Using Saliva and Stool Samples During Colonoscopy
Led by Viome · Updated on 2026-08-26
1000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a noninvasive molecular diagnostic test to detect colorectal polyps. This observational study is a collaboration between Viome Life Sciences and Scripps Research Institute. About 1,000 adults scheduled for colonoscopy will participate to help develop and validate a predictive model linking molecular features from saliva and stool samples to colonoscopy findings. Participants will provide saliva and stool samples between 4 weeks and 1 day before starting bowel preparation for their colonoscopy. The study involves no interventions and focuses on collecting these samples prior to the procedure. The collected molecular data will be analyzed and compared with colonoscopy and pathology results to develop and then validate the tests performance. Throughout the study, participants will undergo their scheduled colonoscopy with associated pathology results recorded electronically. Researchers will assess the diagnostic performance of the molecular test by comparing it with colonoscopy outcomes. The total participation time includes the sample collection period before colonoscopy and the follow-up of electronic medical records to confirm findings. The study aims to improve detection methods for colorectal polyps through this molecular approach.
CONDITIONS
Brief Title
Metatranscriptomic Markers of Colonic Neoplasia
Research Team
M
Momchilo Vuyisich, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here